Vaginal Cancer Global Clinical Trials Review, H2, 2012
Upcoming SlideShare
Loading in...5
×
 

Vaginal Cancer Global Clinical Trials Review, H2, 2012

on

  • 238 views

 

Statistics

Views

Total Views
238
Views on SlideShare
238
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Vaginal Cancer Global Clinical Trials Review, H2, 2012 Vaginal Cancer Global Clinical Trials Review, H2, 2012 Document Transcript

  • Vaginal Cancer Global Clinical Trials Review, H2, 2012Report Details:Published:November 2012No. of Pages: 81Price: Single User License – US$2500Vaginal Cancer Global Clinical Trials Review, H2, 2012SummaryGlobalDatas clinical trial report, “Vaginal Cancer Global Clinical Trials Review, H2, 2012"provides data on the Vaginal Cancer clinical trial scenario. This report provides elementalinformation and data relating to the clinical trials on Vaginal Cancer. It includes an overview of thetrial numbers and their recruitment status as per the site of trial conduction across the globe. Thedatabook offers a preliminary coverage of disease clinical trials by their phase, trial status,prominence of the sponsors and also provides briefing pertaining to the number of trials for the keydrugs for treating Vaginal Cancer. This report is built using data and information sourced fromproprietary databases, primary and secondary research and in-house analysis by GlobalDatasteam of industry experts.Note: Certain sections in the report may be removed or altered based on the availability andrelevance of data for the indicated disease.Scope- Data on the number of clinical trials conducted in North America, South and Central America,Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, alongwith the clinical trial scenario in BRIC nations- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited andsponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)Reasons to buy- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location,sponsor type and many more
  • - Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesGet your copy of this report @http://www.reportsnreports.com/reports/210598-vaginal-cancer-global-clinical-trials-review-h2-2012.htmlMajor points covered in Table of Contents of this report includeTable of ContentsTable of Contents 2List of Tables 4List of Figures 5Introduction 6Vaginal Cancer 6Report Guidance 6Clinical Trials by Region 7Clinical Trials by Country 8Top Five Countries Contributing to Clinical Trials in Europe 10Top Countries Contributing to Clinical Trials in North America 11Clinical Trials by G7 Nations 12Clinical Trials in G7 Nations by Trial Status 13Clinical Trials by Phase 14In Progress Trials by Phase 15Clinical Trials by Trial Status 16Unaccomplished Trials of Vaginal Cancer 17Subjects Recruited Over a Period of Time 18Prominent Sponsors 19Prominent Drug Comparison 21Clinical Trial Profiles 22Clinical Trial Overview of Top Companies 22Merck & Co., Inc. 22Clinical Trial Overview of Merck & Co., Inc. 22Clinical Trial Overview of Top Universities / Institutes / Hospitals 23Case Comprehensive Cancer Center 23Clinical Trial Overview of Case Comprehensive Cancer Center 23Memorial Sloan Kettering Cancer Center 24Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 24The University of Texas M. D. Anderson Cancer Center 25Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 25Dana-Farber Cancer Institute 26Clinical Trial Overview of Dana-Farber Cancer Institute 26Masonic Cancer Center 27Clinical Trial Overview of Masonic Cancer Center 27Centre Oscar Lambret 28
  • Clinical Trial Overview of Centre Oscar Lambret 28U.S. Army Medical Research Institute of Infectious Diseases 29Clinical Trial Overview of U.S. Army Medical Research Institute of Infectious Diseases 29Absenger Cancer Education Foundation 30Clinical Trial Overview of Absenger Cancer Education Foundation 30University of Maryland Greenebaum Cancer Center 31Clinical Trial Overview of University of Maryland Greenebaum Cancer Center 31NYU Cancer Institute 32Clinical Trial Overview of NYU Cancer Institute 32Maastricht Radiation Oncology 33Clinical Trial Overview of Maastricht Radiation Oncology 33Brigham and Womens Hospital 34Clinical Trial Overview of Brigham and Womens Hospital 34Fred Hutchinson Cancer Research Center 35Clinical Trial Overview of Fred Hutchinson Cancer Research Center 35The University of Chicago 36Clinical Trial Overview of The University of Chicago 36University of Toronto 37Clinical Trial Overview of University of Toronto 37Northwestern University 38Clinical Trial Overview of Northwestern University 38Roswell Park Cancer Institute 39Clinical Trial Overview of Roswell Park Cancer Institute 39Leiden University Medical Center 40Clinical Trial Overview of Leiden University Medical Center 40University Health Network 41Clinical Trial Overview of University Health Network 41Five Key Clinical Profiles 42Appendix 78Abbreviations 78Definitions 78Research Methodology 79Secondary Research 79About GlobalData 80Contact Us 80Disclaimer 80Source 81List of TablesVaginal Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
  • Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 11Vaginal Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 12Vaginal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 14Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 15Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16Vaginal Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 17Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 18Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20Vaginal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc.,2012* 22Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by CaseComprehensive Cancer Center, 2012* 23Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial SloanKettering Cancer Center, 2012* 24Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofTexas M. D. Anderson Cancer Center, 2012* 25Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber CancerInstitute, 2012* 26Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic CancerCenter, 2012* 27Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre OscarLambret, 2012* 28Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army MedicalResearch Institute of Infectious Diseases, 2012* 29Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Absenger CancerEducation Foundation, 2012* 30Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University ofMaryland Greenebaum Cancer Center, 2012* 31Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NYU CancerInstitute, 2012* 32Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht RadiationOncology, 2012* 33Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham andWomens Hospital, 2012* 34Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred HutchinsonCancer Research Center, 2012* 35Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University ofChicago, 2012* 36
  • Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto,2012* 37Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NorthwesternUniversity, 2012* 38Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park CancerInstitute, 2012* 39Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden UniversityMedical Center, 2012* 40Vaginal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University HealthNetwork, 2012* 41List of FiguresVaginal Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9Vaginal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10Vaginal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11Vaginal Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 12Vaginal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 13Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 14Vaginal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 15Vaginal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 16Vaginal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 18Vaginal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 19Vaginal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 21GlobalData Methodology 79Contact: sales@reportsandreports.com for more information.